| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...988739H |
| P356 | DOI | 10.1371/JOURNAL.PONE.0088739 |
| P932 | PMC publication ID | 3919806 |
| P698 | PubMed publication ID | 24520420 |
| P5875 | ResearchGate publication ID | 260150669 |
| P2093 | author name string | Markus A Ruegg | |
| Shuo Lin | |||
| Filippo Oliveri | |||
| Stefan Hettwer | |||
| Monika Haubitz | |||
| Jan W Vrijbloed | |||
| Ruggero G Fariello | |||
| Stefan Kucsera | |||
| P2860 | cites work | The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis | Q27008264 |
| Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse | Q28185780 | ||
| The muscle protein Dok-7 is essential for neuromuscular synaptogenesis | Q28247970 | ||
| The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo | Q28280767 | ||
| Defective neuromuscular synaptogenesis in agrin-deficient mutant mice | Q28280786 | ||
| Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation | Q28507760 | ||
| Agrin and synaptic laminin are required to maintain adult neuromuscular junctions | Q28511069 | ||
| Alternatively spliced isoforms of nerve- and muscle-derived agrin: their roles at the neuromuscular junction | Q28513062 | ||
| Neurotrypsin cleaves agrin locally at the synapse | Q28513643 | ||
| LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction | Q28592974 | ||
| Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP | Q29547505 | ||
| Muscle-wide secretion of a miniaturized form of neural agrin rescues focal neuromuscular innervation in agrin mutant mice | Q30482979 | ||
| Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location | Q30534999 | ||
| Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers | Q33788155 | ||
| Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise | Q34093370 | ||
| Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy. | Q50786048 | ||
| Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. | Q54631945 | ||
| MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity | Q61855429 | ||
| DAB cytochemistry: artifact problems in its current uses | Q71303690 | ||
| Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin | Q79165764 | ||
| Denervation produces different single fiber phenotypes in fast- and slow-twitch hindlimb muscles of the rat | Q83149945 | ||
| Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients | Q83703672 | ||
| Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia | Q84874688 | ||
| The agrin gene codes for a family of basal lamina proteins that differ in function and distribution | Q34234963 | ||
| New insights into the roles of agrin | Q35097331 | ||
| A valid mouse model of AGRIN-associated congenital myasthenic syndrome. | Q35532941 | ||
| Effects of aging on muscle fibre type and size | Q35907563 | ||
| Mitochondrial signaling contributes to disuse muscle atrophy. | Q36114865 | ||
| Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation | Q36173668 | ||
| Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site | Q36382434 | ||
| Localization of acetylcholine receptor by 125I-labeled alpha-bungarotoxin binding at mouse motor endplates | Q36517854 | ||
| Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments | Q36805205 | ||
| The role of MuSK in synapse formation and neuromuscular disease | Q38103527 | ||
| Koelle's copper thiocholine method performed with a low-pH phosphate buffer, followed by osmification of the precipitate: revival of two abandoned procedures | Q39239602 | ||
| Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction | Q39639185 | ||
| Increasing MuSK activity delays denervation and improves motor function in ALS mice | Q41877091 | ||
| Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis | Q42285046 | ||
| Autoantibodies in myasthenia gravis | Q43751539 | ||
| Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. | Q44241210 | ||
| Expression of mouse agrin in normal, denervated and dystrophic muscle | Q44473154 | ||
| The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo | Q46488107 | ||
| Purification and enzymological characterization of murine neurotrypsin | Q46520674 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuromuscular junction | Q776995 |
| P304 | page(s) | e88739 | |
| P577 | publication date | 2014-02-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction | |
| P478 | volume | 9 |
| Q28080339 | Ageing in relation to skeletal muscle dysfunction: redox homoeostasis to regulation of gene expression |
| Q47169869 | Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules |
| Q36480379 | Cervical spinal cord injury exacerbates ventilator-induced diaphragm dysfunction |
| Q52329483 | Collagen XIII Is Required for Neuromuscular Synapse Regeneration and Functional Recovery after Peripheral Nerve Injury. |
| Q33658756 | Degeneration of neuromuscular junction in age and dystrophy |
| Q37602392 | Dietary supplementation with bovine-derived milk fat globule membrane lipids promotes neuromuscular development in growing rats |
| Q93055041 | Dissecting the Extracellular Complexity of Neuromuscular Junction Organizers |
| Q47570833 | Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis |
| Q33563640 | Functional decline at the aging neuromuscular junction is associated with altered laminin-α4 expression |
| Q49304342 | Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy. |
| Q52692587 | MYO9A deficiency in motor neurons is associated with reduced neuromuscular agrin secretion. |
| Q92503428 | Modulation of Agrin and RhoA Pathways Ameliorates Movement Defects and Synapse Morphology in MYO9A-Depleted Zebrafish |
| Q64992976 | Motor Endplate-Anatomical, Functional, and Molecular Concepts in the Historical Perspective. |
| Q90600895 | NMJ maintenance and repair in aging |
| Q92702298 | Neuromuscular Junction as an Entity of Nerve-Muscle Communication |
| Q26766502 | Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy |
| Q37097233 | Neuromuscular junction degeneration in muscle wasting |
Search more.